A randomized, double-blind, placebo-controlled phase II study of eculizumab in patients with refractory generalized myasthenia gravis - Howard, JF, Jr; Barohn, RJ; Cutter, GR; Freimer, M; Juel, VC; Mozaffar, T; Mellion, ML; Benatar, MG; Farrugia, ME; Wang, JJ; Malhotra, SS; Kissel, JT (Muscle Nerve, 2013)